91 related articles for article (PubMed ID: 14743438)
1. A non-peptide substance P antagonist (CP-96,345) inhibits morphine-induced NF-kappa B promoter activation in human NT2-N neurons.
Wang X; Douglas SD; Commons KG; Pleasure DE; Lai J; Ho C; Bannerman P; Williams M; Ho W
J Neurosci Res; 2004 Feb; 75(4):544-53. PubMed ID: 14743438
[TBL] [Abstract][Full Text] [Related]
2. Morphine upregulates functional expression of neurokinin-1 receptor in neurons.
Wan Q; Douglas SD; Wang X; Kolson DL; O'Donnell LA; Ho WZ
J Neurosci Res; 2006 Nov; 84(7):1588-96. PubMed ID: 16983662
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes.
Guo CJ; Douglas SD; Gao Z; Wolf BA; Grinspan J; Lai JP; Riedel E; Ho WZ
Glia; 2004 Nov; 48(3):259-66. PubMed ID: 15390113
[TBL] [Abstract][Full Text] [Related]
4. Human neuronal cells (NT2-N) express functional substance P and neurokinin-1 receptor coupled to MIP-1 beta expression.
Li Y; Douglas SD; Pleasure DE; Lai J; Guo C; Bannerman P; Williams M; Ho W
J Neurosci Res; 2003 Feb; 71(4):559-66. PubMed ID: 12548712
[TBL] [Abstract][Full Text] [Related]
5. Substance P up-regulates macrophage inflammatory protein-1beta expression in human T lymphocytes.
Guo CJ; Lai JP; Luo HM; Douglas SD; Ho WZ
J Neuroimmunol; 2002 Oct; 131(1-2):160-7. PubMed ID: 12458047
[TBL] [Abstract][Full Text] [Related]
6. Expression of functional NK1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF-kappaB pathway.
Bardelli C; Gunella G; Varsaldi F; Balbo P; Del Boca E; Bernardone IS; Amoruso A; Brunelleschi S
Br J Pharmacol; 2005 Jun; 145(3):385-96. PubMed ID: 15778738
[TBL] [Abstract][Full Text] [Related]
7. The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells.
Davis RL; Buck DJ; Saffarian N; Stevens CW
J Neuroimmunol; 2007 May; 186(1-2):141-9. PubMed ID: 17475341
[TBL] [Abstract][Full Text] [Related]
8. Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves Rho family small GTPases.
Zhao D; Kuhnt-Moore S; Zeng H; Pan A; Wu JS; Simeonidis S; Moyer MP; Pothoulakis C
Biochem J; 2002 Dec; 368(Pt 2):665-72. PubMed ID: 12169092
[TBL] [Abstract][Full Text] [Related]
9. Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves protein kinase Cdelta activation.
Koon HW; Zhao D; Zhan Y; Simeonidis S; Moyer MP; Pothoulakis C
J Pharmacol Exp Ther; 2005 Sep; 314(3):1393-400. PubMed ID: 15917399
[TBL] [Abstract][Full Text] [Related]
10. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.
Johnson EA; Oldfield S; Braksator E; Gonzalez-Cuello A; Couch D; Hall KJ; Mundell SJ; Bailey CP; Kelly E; Henderson G
Mol Pharmacol; 2006 Aug; 70(2):676-85. PubMed ID: 16682505
[TBL] [Abstract][Full Text] [Related]
11. Opioid-induced chemokine expression requires NF-κB activity: the role of PKCζ.
Happel C; Kutzler M; Rogers TJ
J Leukoc Biol; 2011 Feb; 89(2):301-9. PubMed ID: 20952659
[TBL] [Abstract][Full Text] [Related]
12. Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins.
Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Garzón J
Mol Pain; 2007 Jul; 3():19. PubMed ID: 17634133
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of the inhibition of nuclear factor-κB by morphine in neuronal cells.
Börner C; Höllt V; Kraus J
Mol Pharmacol; 2012 Apr; 81(4):587-97. PubMed ID: 22258905
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Ca2+ channels by heterologously expressed wild-type and mutant human micro-opioid receptors (hMORs) containing the A118G single-nucleotide polymorphism.
Margas W; Zubkoff I; Schuler HG; Janicki PK; Ruiz-Velasco V
J Neurophysiol; 2007 Feb; 97(2):1058-67. PubMed ID: 17151221
[TBL] [Abstract][Full Text] [Related]
15. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
[TBL] [Abstract][Full Text] [Related]
16. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
Al-Khrasani M; Spetea M; Friedmann T; Riba P; Király K; Schmidhammer H; Furst S
Brain Res Bull; 2007 Oct; 74(5):369-75. PubMed ID: 17845912
[TBL] [Abstract][Full Text] [Related]
17. Morphine Up-regulates expression of substance P and its receptor in human blood mononuclear phagocytes and lymphocytes.
Li Y; Tian S; Douglas SD; Ho WZ
Cell Immunol; 2000 Nov; 205(2):120-7. PubMed ID: 11104584
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of the gerbil writhing response by mu-, kappa- and delta-opioids, and NK-1, -2 and -3 receptor antagonists.
Gallantine EL; Meert TF
Pharmacol Biochem Behav; 2004 Sep; 79(1):125-35. PubMed ID: 15388292
[TBL] [Abstract][Full Text] [Related]
19. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
20. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
Sterious SN; Walker EA
J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
